Goldshield Pharmaceuticals Primary Care UK
Goldshield Pharmaceuticals Primary Care UK
Goldshield Pharmaceuticals Primary Care UK
Goldshield Pharmaceuticals Primary Care UK
Goldshield Pharmaceuticals Primary Care UK
Goldshield Pharmaceuticals Primary Care UK
Goldshield Pharmaceuticals Primary Care UK
Goldshield Pharmaceuticals Primary Care UK

Stelazine

Stelazine 5mg
  • Stelazine contains Trifluoperazine which is a Piperazine Phenothiazine Tranquiliser with potent Anti-Psychotic, Anxiolytic and Antiemetic activity and a Pharmacological profile of moderate sedative and Hypotensive properties and fairly pronounced tendency to cause extra Pyramidal reactions

Therapeutic Indications:

Low Dosage

  • ‘Stelazine’ is indicated as an adjunct in the short-term management of Anxiety states, Depressive Symptoms secondary to Anxiety and Agitation
  • It is also indicated in the Symptomatic treatment of Nausea and Vomiting

High Dosage

  • Treatment of symptoms and prevention of Relapse in Schizophrenia and in other Psychoses, especially of the Paranoid type, but not in Depressive Psychoses
  • It may also be used as an adjunct in the short-term management of Severe Psychomotor Agitation and of dangerously impulsive behaviour in, for example, Mental Sub Normality

Presentation

  • Trifluroperazine Hydrochloride 1mg
  • Trifluoperazine Hydrochloride 5mg
  • Each 5ml dose contains 1mg Trifluoperazine present as the Hydrochloride

You will need Adobe Acrobat Reader to view these files. Get Adobe Reader HereGet Adobe Reader

Sumary of Product Characteristics Patient Information Leaflet
Stelazine Syrup
Stelazine Tablets
Stelazine Syrup
Stelazine Tablets